Results 201 to 210 of about 6,419 (213)

Pfizer to manufacture Paxlovid in Kalamazoo

Chemical & Engineering News, 2022
openaire   +1 more source

Paxlovid for hospitalized COVID-19 patients with chronic kidney disease

Antiviral Research, 2023
exaly  

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022

Morbidity and Mortality Weekly Report, 2022
exaly  

Decision letter for "Paxlovid‐associated dysgeusia"

2022
openaire   +2 more sources

Covid-19: FDA authorises pharmacists to prescribe Paxlovid

BMJ, 2022
openaire   +2 more sources

Is Paxlovid Still Worth It?

Clinical Infectious Diseases
Jeremy Samuel Faust, Gideon Meyerowitz-Katz   +1 more
openaire   +2 more sources

Three more points about Paxlovid for covid-19

BMJ, 2022
openaire   +2 more sources

Author response for "Paxlovid‐associated dysgeusia"

2022
null John K. Brooks, null Julia H. Song, null Ahmed S. Sultan   +2 more
openaire   +1 more source

A tale of two antiviral targets — and the COVID-19 drugs that bind them

Nature Reviews Drug Discovery, 2022
exaly  

Paxlovid for a patient on DOAC

2022
openaire   +1 more source